INS and alkaline phosphatase measurement: AP might also worsen the course of DM by adversely affecting the pancreas, considering mechanisms of pancreatogenic diabetes including loss of islet cell mass, AP-induced autoimmunity, shared risk factors for AP and diabetes, local and systemic inflammatory response, alterations in the insulin–incretin axis, and a combination of these factors [30].